Vaccine development - 1 News from the research and development department by University of Texas MD Anderson Cancer Center for the pharma industry

Tip: You can further refine your news selection by countries.

Vaccine development - 1 News from the research and development department by University of Texas MD Anderson Cancer Center for the pharma industry

Tip: You can further refine your news selection by countries.

image description

CureVac and MD Anderson enter strategic collaboration to develop novel cancer vaccines

Collaboration aims to develop novel, off-the-shelf, mRNA-based cancer vaccines in selected hematological and solid cancers with high unmet medical need

17-Apr-2024 - CureVac N.V. and The University of Texas MD Anderson Cancer Center announced a co-development and licensing agreement to develop novel mRNA-based cancer vaccines. The collaboration creates strong synergies between CureVac’s unique end-to-end capabilities for cancer antigen discovery, mRNA design, ...

vaccine development cancer cancer vaccines

These products might interest you

Tangential Flow Filtration (TFF) Solutions

Tangential Flow Filtration (TFF) Solutions by Sartorius

Tangential Flow Filtration Systems

Process Solutions for Ultrafiltration and Diafiltration

filtration systems
View product
Genomics & Analytical Services

Genomics & Analytical Services by Azenta

Integrated Genomics & Analytical Services from Azenta Life Sciences

Discovery can be challenging work. Until you find the right genomics partner.

analytical services
View product
Show all vaccine development
Haven't found the right news yet?

The bionity.com news search

Start your targeted search now with a wide range of filter options. Our database includes an archive of 27,220 life science news from business and science, which you can search by topic and organization, filtered by time and geography.

Start news search now